netFormulary The Pennine Acute Hospitals NHS
NHS Trust Formulary  
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 3 of 3

UPD Leuprorelin (Prostap) note For use in prostate cancer, see section "Amber" for licensed indications, "Red" for all unlicensed uses.
25/11/2014 10:01:19
(ec01ph )
UPD Leuprorelin (Prostap) Prefilled dual chamber syringe 3.75mg (monthly) 11.25mg (every 3 months)
25/11/2014 10:00:31
(ec01ph )
UPD Leuprorelin
Status changed to formulary - published
15/10/2014 12:46:33
(mm02ph )